Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandrine Rorive

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancerLaurence Buisseret, Christine Desmedt, Soizic Garaud, et al.
Journal for Immunotherapy of Cancer|May 24, 2025
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trialJérémy Blanc, Aurélien Carnot, Philippe Barthélémy, et al.
Critical Care (London, England)|August 14, 2020
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patientsMyriam Remmelink, Ricardo De Mendonça, Nicky D'Haene, et al.
Nature Cancer|February 5, 2022
NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiationFederico Mauri, Corentin Schepkens, Gaëlle Lapouge, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 17, 2017
Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancerLaurence Buisseret, Christine Desmedt, Soizic Garaud, et al.
Journal for Immunotherapy of Cancer|May 24, 2025
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trialJérémy Blanc, Aurélien Carnot, Philippe Barthélémy, et al.
Critical Care (London, England)|August 14, 2020
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patientsMyriam Remmelink, Ricardo De Mendonça, Nicky D'Haene, et al.
Nature Cancer|February 5, 2022
NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiationFederico Mauri, Corentin Schepkens, Gaëlle Lapouge, et al.
Pageof 7